Development of 60 MHz integrated backscatter intravascular ultrasound and tissue characterization of attenuated signal coronary plaques that cause myocardial injury after percutaneous coronary intervention

Heart Vessels. 2022 Oct;37(10):1689-1700. doi: 10.1007/s00380-022-02080-5. Epub 2022 May 7.

Abstract

The purpose of the present study was to develop a 60 MHz integrated backscatter intravascular ultrasound (IB-IVUS) and to evaluate its usefulness for the detection of lipid area with backward attenuation of ultrasound signal (AT) that for the prediction of post-procedural myocardial injury (PMI) after percutaneous coronary intervention (PCI). In a pathological study, images were acquired from 221 cross-sections of 18 coronary arteries from 13 cadavers obtained at autopsy. In the clinical training study, we compared non-targeted plaques in 38 patients by a previous IB-IVUS system (38 MHz) and a new IB-IVUS system (60 MHz). In the clinical testing study, we included 70 consecutive patients who underwent PCI. Serum troponin-I was measured just before and 24 h after PCI to evaluate PMI. As the % microcalcification + % cholesterol cleft area increased, the attenuation of IB values increased (r = 0.56, p < 0.001). The slopes of regression lines of the area of each tissue component between 38 and 60 MHz IB-IVUS were excellent. The lipid pool area with AT tended to be more useful than that of the conventional lipid pool area for the prediction of PMI (p = 0.11). We developed a 60 MHz IB-IVUS imaging system for tissue characterization of coronary plaques. Cutoff value of purple color was the most reliable value for the prediction of PMI.

Keywords: Attenuated plaque; Coronary artery disease; Integrated backscatter; Intravascular ultrasound; Tissue characterization.

MeSH terms

  • Coronary Artery Disease* / diagnosis
  • Coronary Artery Disease* / surgery
  • Coronary Vessels / diagnostic imaging
  • Coronary Vessels / pathology
  • Heart Injuries* / diagnostic imaging
  • Heart Injuries* / etiology
  • Humans
  • Lipids
  • Percutaneous Coronary Intervention* / adverse effects
  • Plaque, Atherosclerotic* / diagnosis
  • Plaque, Atherosclerotic* / pathology
  • Ultrasonography, Interventional / methods

Substances

  • Lipids